For example, it is essential to explore whether LAMC2 specifically influences the invasive phenotype of Tum_1 tumor subtype and whether it can synergize with existing therapeutic strategies, such as immune checkpoint inhibitors, to enhance therapeutic outcomes. The gene discussed is LAMC2; the disease is neoplasm.